Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy

International Braz J Urol

Volumn 37, Issue 3, 2011, Pages 336-346

  Aydogdu, Ozgu ^a   Gokce, Mehmet Ilker ^a   Burgu, Berk ^a   Baltaci, Sumer ^a   Yaman, Onder ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Erectile dysfunction; Penile: Erectile; Prostatectomy; Tadalafil

Indexed keywords

CARBOLINE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR; TADALAFIL;

ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; HUMAN; INNERVATION; MALE; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PENIS; PENIS ERECTION; PHYSIOLOGY; PROSPECTIVE STUDY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; TIME;

CARBOLINES; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; ORGAN SPARING TREATMENTS; PENILE ERECTION; PENIS; PHOSPHODIESTERASE 5 INHIBITORS; PROSPECTIVE STUDIES; PROSTATECTOMY; TIME FACTORS;

EID: 80051907866     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382011000300007     Document Type: Article

References (24)

1. Ries L. A. G., Kosary C. L., Hankey B. F. et al. SEER Cancer Statistic Review, 1973-1994. National Institutes of Health Publication, No. 97-2789. Bethesda, Maryland: National Cancer Institute. 1997.
2. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, et al.: EAU guidelines on prostate cancer. Eur Urol. 2005; 48: 546-51.
3. Penson, D. F. and Litwin, M. S. Quality of life issues in patients with prostate cancer. AUA Update Series, vol. 20. Houston, TX: AUA Office of Education 2001;18-24.
4. Karakiewicz PI, Tanguay S, Kattan MW, Elhilali MM, Aprikian AG: Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men. Eur Urol. 2004; 46: 188-94.
5. Dubbelman YD, Dohle GR, Schröder FH: Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol. 2006; 50: 711-8; discussion 718-20.
6. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL: Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol. 2004; 45: 123-33.
7. Fraiman MC, Lepor H, McCullough AR: Changes in Penile Morphometrics in Men with Erectile Dysfunction after Nerve-Sparing Radical Retropubic Prostatectomy. Mol Urol. 1999; 3: 109-115.
8. Briganti A, Fabbri F, Salonia A, Gallina A, Chun FK, Dehò F, et al.: Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol. 2007; 52: 702-7.
9. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, et al.: Effect of nightly versus ondemand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008; 54: 924-31.
10. Teloken P, Mesquita G, Montorsi F, Mulhall J: Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med. 2009; 6: 2032-8.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97.
12. Munding MD, Wessells HB, Dalkin BL: Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology. 2001; 58: 567-9.
13. Mulhall JP: Penile length changes after radical prostatectomy. BJU Int. 2005; 96: 472-4.
14. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT: Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol. 2003; 169: 1175-9.
15. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, et al.: Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl. 2003; 24: 239-45.
16. Savoie M, Kim SS, Soloway MS: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol. 2003; 169: 1462-4.
17. Ciancio SJ, Kim ED: Penile fibrotic changes after radical retropubic prostatectomy. BJU Int. 2000; 85: 101-6.
18. McCullough AR Lepor H: The loss of penile length and circumference in impotent men after nerve sparing radical prostatectomy. J Urol. 1998; (suppl 159): 98. # Abstract 376.
19. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V: Histological alterations in cavernous tissue after radical prostatectomy. J Urol. 2005; 173: 1673-6.
20. Schwartz EJ, Wong P, Graydon RJ: Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004; 171: 771-4.
21. Bianco F, Kattan M, Eastham J, Scardino PT, Mulhall JP: Surgeon and surgical volume as predictors of erectile function outcomes following radical prostatectomy. J Sex Med. 2004; 1(suppl 1): 33. # Abstract O15.
22. Wessells H, Lue TF, McAninch JW: Complications of penile lengthening and augmentation seen at 1 referral center. J Urol. 1996; 155: 1617-20.
23. Supuran CT, Mastrolorenzo A, Barbaro G, Scozzafava A: Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. Curr Pharm Des. 2006; 12: 3459-65.
24. Doggrell S: Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? Int J Impot Res. 2007; 19: 281-95.